This announcement is a separate document:
东诚药业：关于收购中泰生物制品有限公司70%股权事项获得山东省发改委和商务厅备案的公告
Dongcheng Pharmaceutical: Notice on the acquisition of 70% of the shares of Zhongtai Biological Products Co., Ltd. filed with the Shandong Provincial Development and Reform Commission and the Department of Commerce
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.